Work

652PRKER-065 improved the therapeutic response to phosphorodiamidate morpholino oligomers (PMO) in a Duchenne muscular dystrophy mouse model

Year: 2025

Type: article

Source: Neuromuscular Disorders

DOI: 10.1016/j.nmd.2025.105628

Authors: F. Fisher, G. Zhen, R. Nathan, M. Linzey, F. Hack, M. Cahill, T. Daman, S. Macaluso, R. Todorova, R. Grenha, J. Lachey, L. Lerner, J. Seehra

Institution: Keros Therapeutics (United States)

Language: English

Topic: Muscle Physiology and Disorders

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4414824044

FWCI:

Cites:

Cited by:

Related to: 10